Diversify Advisory Services LLC purchased a new position in shares of CME Group Inc. (NASDAQ:CME – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 4,126 shares of the financial services provider’s stock, valued at approximately $946,000.
Other institutional investors and hedge funds have also made changes to their positions in the company. Truvestments Capital LLC purchased a new stake in CME Group during the third quarter worth approximately $26,000. Dunhill Financial LLC lifted its position in shares of CME Group by 188.4% during the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock worth $27,000 after buying an additional 81 shares during the last quarter. Fortitude Family Office LLC boosted its holdings in shares of CME Group by 120.3% in the 4th quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock valued at $35,000 after buying an additional 83 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. grew its position in shares of CME Group by 62.2% in the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after buying an additional 74 shares during the last quarter. Finally, Anchor Investment Management LLC raised its stake in CME Group by 52.4% during the 3rd quarter. Anchor Investment Management LLC now owns 378 shares of the financial services provider’s stock worth $83,000 after acquiring an additional 130 shares in the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
CME has been the topic of several research reports. Morgan Stanley raised their price objective on CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a report on Thursday, October 17th. Oppenheimer lifted their price target on CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a research report on Thursday, October 24th. Deutsche Bank Aktiengesellschaft decreased their price objective on CME Group from $227.00 to $226.00 and set a “hold” rating for the company in a report on Monday, November 11th. Citigroup cut shares of CME Group from a “buy” rating to a “neutral” rating and cut their target price for the company from $255.00 to $250.00 in a report on Monday, January 6th. Finally, The Goldman Sachs Group increased their price target on shares of CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a research note on Thursday, October 3rd. Four research analysts have rated the stock with a sell rating, eight have given a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, CME Group currently has an average rating of “Hold” and a consensus target price of $229.27.
Insider Buying and Selling
In related news, insider Sunil Cutinho sold 4,500 shares of the firm’s stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $226.64, for a total transaction of $1,019,880.00. Following the sale, the insider now owns 27,053 shares in the company, valued at approximately $6,131,291.92. This trade represents a 14.26 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Timothy S. Bitsberger sold 1,000 shares of the firm’s stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $226.96, for a total value of $226,960.00. Following the sale, the director now owns 10,589 shares in the company, valued at $2,403,279.44. This trade represents a 8.63 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 7,274 shares of company stock worth $1,648,071 in the last quarter. Company insiders own 0.30% of the company’s stock.
CME Group Stock Up 0.2 %
CME Group stock opened at $232.71 on Tuesday. The stock’s 50 day moving average price is $233.29 and its 200 day moving average price is $220.09. The company has a market cap of $83.86 billion, a PE ratio of 24.47, a price-to-earnings-growth ratio of 4.93 and a beta of 0.56. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $249.02.
CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. The business had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The business’s revenue for the quarter was up 18.4% on a year-over-year basis. During the same period in the prior year, the company posted $2.25 EPS. On average, sell-side analysts predict that CME Group Inc. will post 10.2 EPS for the current fiscal year.
CME Group Increases Dividend
The company also recently declared a dividend, which was paid on Thursday, January 16th. Stockholders of record on Friday, December 27th were paid a dividend of $5.80 per share. This is a positive change from CME Group’s previous dividend of $2.50. The ex-dividend date of this dividend was Friday, December 27th. CME Group’s payout ratio is 48.37%.
CME Group declared that its board has approved a share buyback plan on Thursday, December 5th that authorizes the company to buyback $3.00 billion in shares. This buyback authorization authorizes the financial services provider to reacquire up to 3.4% of its shares through open market purchases. Shares buyback plans are often an indication that the company’s board of directors believes its stock is undervalued.
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Articles
- Five stocks we like better than CME Group
- What is an Earnings Surprise?
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- Investing in Commodities: What Are They? How to Invest in Them
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- Using the MarketBeat Dividend Tax Calculator
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.